Literature DB >> 20160136

Selective activation of estrogen receptor-beta target genes by 3,3'-diindolylmethane.

Omar I Vivar1, Elise F Saunier, Dale C Leitman, Gary L Firestone, Leonard F Bjeldanes.   

Abstract

3,3'-Diindolylmethane (DIM) is a natural compound found in cruciferous vegetables that has antiproliferative and estrogenic activity. However, it is not clear whether the estrogenic effects are mediated through estrogen receptor (ER)alpha, ERbeta, or both ER subtypes. We investigated whether DIM has ER subtype selectivity on gene transcription. DIM stimulated ERbeta but not ERalpha activation of an estrogen response element upstream of the luciferase reporter gene. DIM also selectively activated multiple endogenous genes through ERbeta. DIM did not bind to ERbeta, indicating that it activates genes by a ligand-independent mechanism. DIM causes ERbeta to bind regulatory elements and recruit the steroid receptor coactivator (SRC)-2 coactivator, which leads to the activation of ER target genes. Silencing of SRC-2 inhibited the activation of ER target genes, demonstrating that SRC-2 is required for transcriptional activation by DIM. Our results demonstrate that DIM is a new class of ERbeta-selective compounds, because it does not bind to ERbeta, but instead it selectively recruits ERbeta and coactivators to target genes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20160136      PMCID: PMC2850231          DOI: 10.1210/en.2009-1028

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  39 in total

1.  p38 mitogen-activated protein kinase stimulates estrogen-mediated transcription and proliferation through the phosphorylation and potentiation of the p160 coactivator glucocorticoid receptor-interacting protein 1.

Authors:  Daniel E Frigo; Aninda Basu; Erica N Nierth-Simpson; Christopher B Weldon; Christine M Dugan; Steven Elliott; Bridgette M Collins-Burow; Virgilio A Salvo; Yun Zhu; Lilia I Melnik; Gabriela N Lopez; Peter J Kushner; Tyler J Curiel; Brian G Rowan; John A McLachlan; Matthew E Burow
Journal:  Mol Endocrinol       Date:  2006-01-12

2.  Unique ERalpha cistromes control cell type-specific gene regulation.

Authors:  Susan A Krum; Gustavo A Miranda-Carboni; Mathieu Lupien; Jerome Eeckhoute; Jason S Carroll; Myles Brown
Journal:  Mol Endocrinol       Date:  2008-09-25

3.  Selective activation of estrogen receptor-beta transcriptional pathways by an herbal extract.

Authors:  Aleksandra Cvoro; Sreenivasan Paruthiyil; Jeremy O Jones; Christina Tzagarakis-Foster; Nicola J Clegg; Deirdre Tatomer; Roanna T Medina; Mary Tagliaferri; Fred Schaufele; Thomas S Scanlan; Marc I Diamond; Isaac Cohen; Dale C Leitman
Journal:  Endocrinology       Date:  2006-11-09       Impact factor: 4.736

4.  Distinct roles of unliganded and liganded estrogen receptors in transcriptional repression.

Authors:  Aleksandra Cvoro; Christina Tzagarakis-Foster; Deirdre Tatomer; Sreenivasan Paruthiyil; Mark S Fox; Dale C Leitman
Journal:  Mol Cell       Date:  2006-02-17       Impact factor: 17.970

5.  Selective estrogen receptor-beta agonists repress transcription of proinflammatory genes.

Authors:  Aleksandra Cvoro; Deirdre Tatomer; Meng-Kian Tee; Tatjana Zogovic; Heather A Harris; Dale C Leitman
Journal:  J Immunol       Date:  2008-01-01       Impact factor: 5.422

6.  Multiple transcription factor elements collaborate with estrogen receptor alpha to activate an inducible estrogen response element in the NKG2E gene.

Authors:  Nitzan Levy; Xiaoyue Zhao; Hui Tang; Robert B Jaffe; Terence P Speed; Dale C Leitman
Journal:  Endocrinology       Date:  2007-03-29       Impact factor: 4.736

7.  Differential regulation of native estrogen receptor-regulatory elements by estradiol, tamoxifen, and raloxifene.

Authors:  Nitzan Levy; Dierdre Tatomer; Candice B Herber; Xiaoyue Zhao; Hui Tang; Toby Sargeant; Lonnele J Ball; Jonathan Summers; Terence P Speed; Dale C Leitman
Journal:  Mol Endocrinol       Date:  2007-10-25

8.  Liquiritigenin is a plant-derived highly selective estrogen receptor beta agonist.

Authors:  Jennifer E Mersereau; Nitzan Levy; Richard E Staub; Scott Baggett; Tatjana Zogovic; Tetjana Zogric; Sylvia Chow; William A Ricke; Mary Tagliaferri; Isaac Cohen; Leonard F Bjeldanes; Dale C Leitman
Journal:  Mol Cell Endocrinol       Date:  2007-11-26       Impact factor: 4.102

9.  3,3'-Diindolylmethane induces a G(1) arrest in human prostate cancer cells irrespective of androgen receptor and p53 status.

Authors:  Omar I Vivar; Chia-Lei Lin; Gary L Firestone; Leonard F Bjeldanes
Journal:  Biochem Pharmacol       Date:  2009-05-09       Impact factor: 5.858

Review 10.  Estrogen receptor beta: an overview and update.

Authors:  Chunyan Zhao; Karin Dahlman-Wright; Jan-Ake Gustafsson
Journal:  Nucl Recept Signal       Date:  2008-02-01
View more
  11 in total

1.  Selective Aryl Hydrocarbon Receptor Modulator 3,3'-Diindolylmethane Impairs AhR and ARNT Signaling and Protects Mouse Neuronal Cells Against Hypoxia.

Authors:  J Rzemieniec; E Litwa; A Wnuk; W Lason; W Krzeptowski; M Kajta
Journal:  Mol Neurobiol       Date:  2015-10-17       Impact factor: 5.590

Review 2.  Minireview: Tipping the balance: ligand-independent activation of steroid receptors.

Authors:  Marcela A Bennesch; Didier Picard
Journal:  Mol Endocrinol       Date:  2015-01-27

Review 3.  Attenuation of multi-targeted proliferation-linked signaling by 3,3'-diindolylmethane (DIM): from bench to clinic.

Authors:  Sanjeev Banerjee; Dejuan Kong; Zhiwei Wang; Bin Bao; Gilda G Hillman; Fazlul H Sarkar
Journal:  Mutat Res       Date:  2011-06-15       Impact factor: 2.433

4.  Estrogen receptor beta binds to and regulates three distinct classes of target genes.

Authors:  Omar I Vivar; Xiaoyue Zhao; Elise F Saunier; Chandi Griffin; Oleg S Mayba; Mary Tagliaferri; Isaac Cohen; Terence P Speed; Dale C Leitman
Journal:  J Biol Chem       Date:  2010-04-19       Impact factor: 5.157

5.  Diindolylmethane, a naturally occurring compound, induces CYP3A4 and MDR1 gene expression by activating human PXR.

Authors:  Satyanarayana R Pondugula; Patrick C Flannery; Kodye L Abbott; Elaine S Coleman; Sridhar Mani; Temesgen Samuel; Wen Xie
Journal:  Toxicol Lett       Date:  2014-12-24       Impact factor: 4.372

Review 6.  Natural compounds as anticancer agents: Experimental evidence.

Authors:  Jiao Wang; Yang-Fu Jiang
Journal:  World J Exp Med       Date:  2012-06-20

7.  A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen.

Authors:  Cynthia A Thomson; H H Sherry Chow; Betsy C Wertheim; Denise J Roe; Alison Stopeck; Gertraud Maskarinec; Maria Altbach; Pavani Chalasani; Chuan Huang; Meghan B Strom; Jean-Philippe Galons; Patricia A Thompson
Journal:  Breast Cancer Res Treat       Date:  2017-05-30       Impact factor: 4.872

Review 8.  Chemopreventive properties of 3,3'-diindolylmethane in breast cancer: evidence from experimental and human studies.

Authors:  Cynthia A Thomson; Emily Ho; Meghan B Strom
Journal:  Nutr Rev       Date:  2016-05-31       Impact factor: 7.110

9.  Fatty acids derived from royal jelly are modulators of estrogen receptor functions.

Authors:  Paraskevi Moutsatsou; Zoi Papoutsi; Eva Kassi; Nina Heldring; Chunyan Zhao; Anna Tsiapara; Eleni Melliou; George P Chrousos; Ioanna Chinou; Andrey Karshikoff; Lennart Nilsson; Karin Dahlman-Wright
Journal:  PLoS One       Date:  2010-12-22       Impact factor: 3.240

10.  Multiple therapeutic and preventive effects of 3,3'-diindolylmethane on cancers including prostate cancer and high grade prostatic intraepithelial neoplasia.

Authors:  William Weiben Zhang; Zhenqing Feng; Steven A Narod
Journal:  J Biomed Res       Date:  2014-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.